Return On Equity of ARS Pharmaceuticals, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ARS Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • ARS Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -39%, a 72% decline year-over-year.
  • ARS Pharmaceuticals, Inc. annual Return On Equity for 2024 was 4%.
  • ARS Pharmaceuticals, Inc. annual Return On Equity for 2023 was -22%, a 77% increase from 2022.
  • ARS Pharmaceuticals, Inc. annual Return On Equity for 2022 was -99%, a 1143% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

ARS Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -39% -16% -72% 01 Jul 2025 30 Sep 2025
Q2 2025 -22% -2% -11% 01 Apr 2025 30 Jun 2025
Q1 2025 -7% +14% +67% 01 Jan 2025 31 Mar 2025
Q4 2024 4% +26% 01 Oct 2024 31 Dec 2024
Q3 2024 -23% +2% +6.7% 01 Jul 2024 30 Sep 2024
Q2 2024 -20% +9% +32% 01 Apr 2024 30 Jun 2024
Q1 2024 -21% +17% +45% 01 Jan 2024 31 Mar 2024
Q4 2023 -22% +77% +77% 01 Oct 2023 31 Dec 2023
Q3 2023 -24% +38% +61% 01 Jul 2023 30 Sep 2023
Q2 2023 -29% -46% -268% 01 Apr 2023 30 Jun 2023
Q1 2023 -39% -33% -584% 01 Jan 2023 31 Mar 2023
Q4 2022 -99% -91% -1143% 01 Oct 2022 31 Dec 2022
Q3 2022 -62% -32% -104% 01 Jul 2022 30 Sep 2022
Q2 2022 17% +59% 01 Apr 2022 30 Jun 2022
Q1 2022 -6% +85% +94% 01 Jan 2022 31 Mar 2022
Q4 2021 -8% -66% -114% 01 Oct 2021 31 Dec 2021
Q3 2021 -31% 01 Jul 2021 30 Sep 2021
Q2 2021 -41% 01 Apr 2021 30 Jun 2021
Q1 2021 -90% 01 Jan 2021 31 Mar 2021
Q4 2020 58% 01 Oct 2020 31 Dec 2020

ARS Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 4% +26% 01 Jan 2024 31 Dec 2024
2023 -22% +77% +77% 01 Jan 2023 31 Dec 2023
2022 -99% -91% -1143% 01 Jan 2022 31 Dec 2022
2021 -8% -66% -114% 01 Jan 2021 31 Dec 2021
2020 58% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.